Daniel S. Och’s OZ Management is among the investment management firms required to disclose their long equity positions once per quarter. Recently,......
(read more)August 22 - Hedge Funds, News - Comments
Legendary corporate raider Carl Icahn recently filed his second quarter Form 13F with the SEC. In this document, the investor disclosed most of his long......
(read more)August 22 - Hedge Funds, News - Comments
In its latest 13F filing, GLG Partners, managed by Noam Gottesman, disclosed equity position as held at the end of June, 2014. The fund reported holding......
(read more)August 15 - Hedge Funds, News - Comments
Harvard Management Company Chief Executive Officer, Jane Mendillo, shared her investment philosophy on CNBC, during an interactive program which was......
(read more)July 17 - Hedge Funds, News - Comments
Clint Carlson’s fund Carlson Capital has disclosed in a recent filing with the SEC a letter sent to the Special Committee of the Board of Directors......
(read more)June 23 - Hedge Funds, News - Comments
Deepak Gulati is the former head of global equity proprietary trading at JPMorgan Chase & Co. (NYSE:JPM) and the founder and manager of Argentiere......
(read more)May 28 - Hedge Funds, News - Comments
Mario Gabelli‘s GAMCO Investors is one of the most prominent funds in the investment universe, which is why we consider that its activity should......
(read more)May 6 - Hedge Funds, News - Comments
Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines......
(read more)September 13 - News - Comments
Editor’s Note: Apple Inc. (NASDAQ:AAPL), Dell Inc. (NASDAQ:DELL), News Corp (NASDAQ:NWSA), Forest Laboratories, Inc. (NYSE:FRX) Icahn says bought......
(read more)September 11 - Hedge Funds - Comments
Orphan drug status, which is given to drugs meant for the treatment of rare diseases, offers drug developers a path to faster approval and enhanced market......
(read more)September 6 - News - Comments
The way to your wallet just might be through your doctor’s eyes. Pharmaceutical firms spend a lot of money to influence physicians to prescribe......
(read more)September 5 - News - Comments
Should Novo Nordisk A/S (ADR) (NYSE:NVO) investors track the following data? In the 21st century investor’s toolkit, there are a multitude of metrics......
(read more)September 5 - News - Comments
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge......
(read more)August 28 - News - Comments
Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments. Schizophrenia treatments Risperdal Consta......
(read more)August 26 - News - Comments
Is Allergan, Inc. (NYSE:AGN) a buy? In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost......
(read more)August 26 - News - Comments
Is Forest Laboratories, Inc. (NYSE:FRX) a sell? If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost......
(read more)August 25 - News - Comments
Editor’s Note: A previous version of this post incorrectly stated that Eli Lilly’s experimental drug solanezumab is a BACE inhibitor. This has been......
(read more)August 23 - News - Comments
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called “Better Know a District,” which highlights......
(read more)August 20 - News - Comments
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......
(read more)August 19 - News - Comments
Second-quarter earnings season was a bit of a bust. Although earnings remain at an all-time high, the pace of earnings growth continues to look weak.......
(read more)August 14 - News - Comments
In June this year, a drug candidate from Cubist Pharmaceuticals Inc (NASDAQ:CBST) received fast track status from the FDA. This product can potentially......
(read more)August 5 - News - Comments
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......
(read more)July 29 - News - Comments
With taxes having risen for most people at the beginning of 2013, ordinary Americans are increasingly angry about the steps that many well-known U.S.......
(read more)July 26 - News - Comments
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable......
(read more)July 10 - News - Comments
The biotech sector can occasionally throw a curveball at investors. For Trius Therapeutics, Inc. (NASDAQ:TSRX) shareholders, they were staring at a meaty......
(read more)March 26 - News - Comments
As first-quarter earnings get ready to kick into high gear, I can’t help but point out that the majority of earnings reports we’ve covered......
(read more)January 22 - News - Comments
In the past two weeks, activist investor Carl Icahn has purchased nearly 420,000 shares of Forest Laboratories, Inc. (NYSE:FRX) worth a total of $14.5......
(read more)September 11 - Hedge Funds, Insider Trading - Comments
Mandel’s Lone Pine Buys Over $400M of Verisign Inc. (ValueWalk) According to a 13G just filled with the Securities and Exchange Commission (SEC), Steven......
(read more)August 28 - Hedge Funds - Comments
Pickens Hedge Fund Soars On Oil (Finalternatives) T. Boone Pickens, who made his billions on oil, is adding to them on the back of the commodity this......
(read more)August 24 - Hedge Funds - Comments
Carl Icahn Isn’t Giving Up the Oshkosh Fight (WSJ) Carl Icahn is pushing a split at truck maker Oshkosh Corp., urging it to spin a unit he’s called......
(read more)August 10 - Hedge Funds - Comments
TrimTabs and BarclayHedge report hedge funds redeem $4.9bn in June 2012 (Opalesque) BarclayHedge and TrimTabs Investment Research reported today that......
(read more)August 9 - Hedge Funds - Comments
Goldman to Invest in City Jail Program, Profiting if Recidivism Falls Sharply (NYTimes) New York City, embracing an experimental mechanism for financing......
(read more)August 2 - Hedge Funds - Comments
Profit rise fuels bumper payday at Tudor in Europe (eFinancialNews) The European arm of the Tudor Group, the US hedge fund founded by Paul Tudor Jones......
(read more)July 26 - Hedge Funds - Comments
I am appealing to you directly because to date my overtures to Howard Solomon have fallen on deaf ears. I am concerned that we are reaching a precipice......
(read more)July 12 - Hedge Funds - Comments
Chairman of Barclays Resigns (NYTimes) Marcus Agius, the chairman of Barclays, resigned on Monday, less than a week after the big British bank agreed......
(read more)July 2 - Hedge Funds - Comments
Falcone’s Harbinger Capital Turns to Dell’s MSD for Loan (Businessweek) Philip Falcone’s hedge fund, having taken out a loan earlier this year at......
(read more)June 20 - Hedge Funds - Comments
